Fed’s favorite inflation gauge looms next week — plus, 2 portfolio earnings reports

Fed’s favorite inflation gauge looms next week — plus, 2 portfolio earnings reports

Wall Street returned to its winning ways this week — and Nvidia ‘s blowout earnings report Wednesday night was a big reason why. All three major U.S. stock benchmarks closed the holiday-shortened week higher, led by the S & P 500 , which rose 1.66% and ended Friday at a record high. The tech-heavy Nasdaq … Read more

AbbVie taps Robert Michael as CEO, succeeding Richard Gonzalez

AbbVie taps Robert Michael as CEO, succeeding Richard Gonzalez

Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. Dado Ruvic | Reuters AbbVie on Tuesday said longtime executive Robert Michael will become the company’s new CEO, replacing Richard Gonzalez.  Michael, who is AbbVie’s president and chief operating officer, will become the company’s second-ever CEO … Read more

We’re making a small trade to add to our newest portfolio position

We’re making a small trade to add to our newest portfolio position

We are buying 85 shares of Abbott Laboratories at roughly $113.91 and selling 60 shares of Procter & Gamble at roughly $158.97. Following the trades, Jim Cramer’s Charitable Trust will own 360 shares of ABT, increasing its weighting to 1.28% from 0.98%, and 490 shares of PG, decreasing its weighting to 2.46% from 2.75%. We’re making … Read more

What to expect when Apple reports quarterly earnings this week

What to expect when Apple reports quarterly earnings this week

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks were mixed Monday to kick off another busy earnings week. The S & P 500 and blue-chip Dow edged lower, while the tech-heavy Nasdaq notched small gains. … Read more

Everything from health care to industrials

Everything from health care to industrials

During the January Monthly Meeting this past Wednesday, we took questions directly from Investing Club members. Here are Jim Cramer’s and Director of Portfolio Analysis Jeff Marks’ responses. Their answers have been edited for clarity. 1. What is a good entry point for Eaton ? It doesn’t seem to want to go down! (Brian) Jim … Read more

What Jim Cramer is watching to see where the stock market goes next

What Jim Cramer is watching to see where the stock market goes next

We don’t know what we want. This week, we will find out what it is that will propel us forward or turn us back after the S & P 500 on Friday closed at a new record high for the first time in more than two years. For example, we have three rails that report … Read more

The S&P 500 set a new record high. How our current Club stocks have fared since the last one

The S&P 500 set a new record high. How our current Club stocks have fared since the last one

The S & P 500 notched a record close Friday for the first time in more than two years — and over that time, no Club stock has performed better than Eli Lilly . The broad market index ended Friday’s session at 4,839.81, edging out its prior all-time high close of 4,796.56 set on Jan. … Read more

Earnings from Procter & Gamble, Tesla, Lockheed Martin

Earnings from Procter & Gamble, Tesla, Lockheed Martin

CNBC’s Jim Cramer on Friday told investors to gear up for a “fast and furious” slew of earnings reports next week that could lead to some profit-taking, including Procter & Gamble, Tesla and Lockheed Martin. This week brought solid gains for the major indexes — with the S&P 500 closing on Friday at an all-time … Read more

We like health-care stocks in 2024 despite presidential election year weakness

We like health-care stocks in 2024 despite presidential election year weakness

As the old Wall Street adage goes, health care tends to underperform the stock market in presidential election years — and in recent cycles, that’s been true. But, there’s reason to believe this year that many health-related stocks, led by Eli Lilly , could defy historical convention. The S & P 500 Health Care Sector … Read more

Jim Cramer’s 4 stock ideas from JPMorgan Healthcare Conference

Jim Cramer’s 4 stock ideas from JPMorgan Healthcare Conference

Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured so much of the growth as Abbott Labs , … Read more